Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to' returned 40 results - Page 1 of 2   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Chinese Markets for Vaccines   AMID Co, Nov 2010, Pages: 298 Flu Vaccine Introduction Flu and Flu Vaccine in China Hepatitis B vaccine Introduction Study for Opportunities Assessment for Hepatitis B Therapeutics in Taiwan   Frost & Sullivan, Dec 2008, Pages: 34 Study for Opportunities Assessment for Hepatitis B Therapeutics in Taiwan This research service aims to provide an update on the epidemiology of hepatitis B, current diagnostic and treatment Opportunities Assessment for Hepatitis B Therapeutics Market in Indonesia   Frost & Sullivan, March 2009, Pages: 36 Opportunities Assessment for Hepatitis B Therapeutics Market in Indonesia This research service aims to provide an update on the epidemiology of hepatitis B, current diagnostic and treatment 2012 France Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 980 of the Disease -- Diagnostic Tests -- Epidemiologic Serosurveys -- Serologic Cross-Reactivity g. Hepatitis G -- Vaccines and Drugs 34. Herpes Simplex Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 2012 Japan Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 976 Serosurveys -Serologic Cross-Reactivity g. Hepatitis G -Vaccines and Drugs 34. Herpes Simplex Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 35. Human Herpes Virus-6 (HHV-6) a. Background -HIV-6 2012 Italy Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 970 Drugs - Vaccines Against HIV - Transmission of HIV in Blood Products - HIV Transmission in Transplant and Artificial Insemination Recipients 2. Adenovirus a. Background b. Diagnostic Tests c. Vaccines Global Microbiology Testing Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers   Venture Planning Group, June 2011, Pages: 1900 Drugs - Vaccines Against HIV 0 Transmission of HIV in Blood Products 0 HIV Transmission in Transplant and Artificial Insemination Recipients 2. Adenovirus a. Background b. Diagnostic Tests c. Vaccines Future French Transfusion Diagnostic Testing Market Outlook   Venture Planning Group, Feb 2012, Pages: 430 Immune Reactions - Epidemiology -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis D (Delta Agent) - Vaccines and Drugs c. Cytomegalovirus - Background - Chorioretinitis - Gastrointestinal - Central Nervous Future German Transfusion Diagnostic Testing Market Outlook   Venture Planning Group, Feb 2012, Pages: 426 B -Hepatitis C -Hepatitis D -Hepatitis E - Virus-Host Immune Reactions - Epidemiology -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis D (Delta Agent) - Vaccines and Drugs c. Cytomegalovirus Future Italian Transfusion Diagnostic Testing Market Outlook   Venture Planning Group, Feb 2012, Pages: 412 - Virus-Host Immune Reactions - Epidemiology -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis D (Delta Agent) - Vaccines and Drugs c. Cytomegalovirus - Background - Chorioretinitis - Gastrointestinal Forecast Insight: Hepatitis B - Baraclude and Viread set to thrive in the face of limited competition   Datamonitor, July 2010, Pages: 67 of the Rest of World countries -Thorough assessment of key marketed products for hepatitis B therapy -Detailed ten-year sales forecasts for marketed hepatitis B drugs in each of the seven major markets The 2011 Italian Blood Banking Market   Venture Planning Group, April 2010, Pages: 410 B -Hepatitis C -Hepatitis D -Hepatitis E - Virus-Host Immune Reactions - Epidemiology -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis D (Delta Agent) - Vaccines and Drugs c. Cytomegalovirus Future Blood Banking Market: Growth Opportunities and Business Expansion Strategies   Venture Planning Group, Nov 2011, Pages: 800 - Overview - Quantitative Polymerase Chain Reaction - In Situ PCR - Needed Improvements - Viral Load/Drug Resistance Testing - Genotype and Phenotype Testing - Blood Banking Considerations b. Hepatitis Growth Opportunities in Transfusion Diagnostic Testing   Venture Planning Group, Feb 2012, Pages: 800 Reactions - Epidemiology - Hepatitis A - Hepatitis B - Hepatitis C - Hepatitis D (Delta Agent) - Vaccines and Drugs c. Cytomegalovirus - Background - Chorioretinitis - Gastrointestinal - Central Nervous 2012 Germany Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 983 -- Serologic Cross-Reactivity g. Hepatitis G -- Vaccines and Drugs 34. Herpes Simplex Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 35. Human Herpes Virus-6 (HHV-6) a. Background -- HIV-6 2012 Spain Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 960 -- Serologic Cross-Reactivity g. Hepatitis G -- Vaccines and Drugs 34. Herpes Simplex Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 35. Human Herpes Virus-6 (HHV-6) a. Background -- HIV-6 The 2011 US Blood Banking Market   Venture Planning Group, April 2010, Pages: 460 -Hepatitis E - Virus-Host Immune Reactions - Epidemiology -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis D (Delta Agent) - Vaccines and Drugs c. Cytomegalovirus - Background - Chorioretinitis The 2011 French Blood Banking Market   Venture Planning Group, April 2010, Pages: 420 B -Hepatitis C -Hepatitis D -Hepatitis E - Virus-Host Immune Reactions - Epidemiology -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis D (Delta Agent) - Vaccines and Drugs c. Cytomegalovirus The 2011 German Blood Banking Market   Venture Planning Group, April 2010, Pages: 420 B -Hepatitis C -Hepatitis D -Hepatitis E - Virus-Host Immune Reactions - Epidemiology -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis D (Delta Agent) - Vaccines and Drugs c. Cytomegalovirus The 2011 Spanish Blood Banking Market   Venture Planning Group, April 2010, Pages: 410 B -Hepatitis C -Hepatitis D -Hepatitis E - Virus-Host Immune Reactions - Epidemiology -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis D (Delta Agent) - Vaccines and Drugs c. Cytomegalovirus Results:  First -   Prev -   1 -   2 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network